TOPIC CENTER
214 Articles
Updated Oct 5, 2026
Strategy & Business
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
-
-
Funding & InvestmentsAmylyx Withdraws ALS Drug Relyvrio Following Trial Failure; Cuts 70% of Staff
4 min read • 2 years ago -
-
-
-
-
Funding & InvestmentsSanofi and Owkin Intensify AI Alliance to Revolutionize Immunology Drug Development
4 min read • 2 years ago -
Funding & InvestmentsLilly Reinforces Chinese Market Commitment Amidst US-China Biotech Tensions
4 min read • 2 years ago -
-
Stay Ahead in Pharma Intelligence
Join industry executives receiving our market briefings.
